Gastrointestinal · PANCE / PANRE

Chronic Pancreatitis

Written & clinically reviewed by Ryan Busch, PA-C · Updated August 2026 · Report an error

Irreversible fibrosis of the pancreas causing pain, exocrine insufficiency, and diabetes.

Also known as: chronic pancreatitis, CP

Overview

Chronic, progressive, fibroinflammatory disease of the pancreas characterized by irreversible structural damage leading to chronic abdominal pain, exocrine insufficiency (steatorrhea, malabsorption), and endocrine insufficiency (diabetes mellitus).

Epidemiology

Prevalence ~50 per 100,000 in the US. Higher prevalence in alcohol users and smokers. Male predominance. Increased risk of pancreatic cancer (4-fold over baseline).

Try two board-style Chronic Pancreatitis questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1GastrointestinalMedium
A 49-year-old man with chronic alcohol use has epigastric pain radiating to the back and steatorrhea. Which of the following best explains his greasy stools?
  • AImpaired colonic water uptake
  • BDecreased pancreatic lipase
  • CReduced hepatic bile output
  • DIncreased gastric acid output
Reveal answer & full explanation
Correct answer: B — Decreased pancreatic lipase
  • AImpaired colonic water uptake
  • BDecreased pancreatic lipase✓
  • CReduced hepatic bile output
  • DIncreased gastric acid output

Why Decreased pancreatic lipase is correct

  • Years of alcohol use produce chronic pancreatitis with progressive exocrine gland destruction.
  • Without pancreatic lipase, dietary fat is not digested or absorbed, so it passes as bulky greasy steatorrhea.
  • Boring epigastric pain radiating to the back plus the alcohol history localizes the injury to the pancreas.

Why the others are wrong

  • Reduced hepatic bile output — Cholestasis can impair fat emulsification, but the back-radiating pain and alcohol history point at the pancreas, not the biliary tree; this is a plausible-organ trap.
  • Increased gastric acid output — Acid hypersecretion drives ulcer pain and dyspepsia, not fat malabsorption, and would not produce oily stools.
  • Impaired colonic water uptake — Defective water reabsorption yields watery, not fatty, diarrhea and does not explain undigested fat.
Question 2GastrointestinalMedium
A 48-year-old man with a 25-year history of heavy alcohol use presents with recurrent, dull epigastric pain that radiates to his back and improves when he leans forward. Over the past year he has lost 12 kg and reports pale, bulky, foul-smelling stools that float and are difficult to flush. He was recently diagnosed with diabetes. He continues to drink and smokes one pack of cigarettes daily. Serum lipase is normal. CT of the abdomen shows scattered pancreatic calcifications, a dilated main pancreatic duct, and parenchymal atrophy. Which of the following is the most likely diagnosis?
  • AAutoimmune IgG4 pancreatitis
  • BPancreatic ductal adenocarcinoma
  • CChronic calcific pancreatitis
  • DRecurrent acute pancreatitis
Reveal answer & full explanation
Correct answer: C — Chronic calcific pancreatitis
  • AAutoimmune IgG4 pancreatitis
  • BPancreatic ductal adenocarcinoma
  • CChronic calcific pancreatitis✓
  • DRecurrent acute pancreatitis

Why Chronic calcific pancreatitis is correct

  • The classic late-stage triad of pancreatic calcifications + steatorrhea + diabetes mellitus is essentially pathognomonic for chronic pancreatitis, and all three are present here.
  • Long-standing heavy alcohol use plus smoking are the dominant toxic-metabolic risk factors (TIGAR-O 'T'); smoking independently accelerates progression.
  • Pain that radiates to the back and eases with leaning forward, weight loss, and greasy floating stools reflect exocrine insufficiency from progressive acinar loss.
  • A normal lipase does NOT exclude the diagnosis: the atrophic, burned-out gland produces little enzyme, so lipase rises only during acute flares.

Why the others are wrong

  • Pancreatic ductal adenocarcinoma — a key mimic to exclude, but it classically causes a discrete pancreatic-head mass with painless obstructive jaundice and an elevated CA 19-9, not diffuse calcifications with ductal dilation and parenchymal atrophy; calcifications point to a chronic fibroinflammatory process.
  • Recurrent acute pancreatitis — presents as distinct episodes with a clearly elevated lipase and normalization between attacks, and lacks the established structural changes (calcifications, atrophy) and exocrine/endocrine failure seen here.
  • Autoimmune IgG4 pancreatitis — a genuine mimic of chronic pancreatitis, but type 1 disease produces a diffusely enlarged sausage-shaped gland with a hypoattenuating capsule-like rim and a diffusely narrowed, featureless main duct, the opposite of the coarse calcifications, dilated main duct, and atrophy seen after 25 years of heavy alcohol use.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Chronic Pancreatitis outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial → Sign in
Free to start · No credit card · Cancel anytime

Risk factors

  • Alcohol — TIGAR-O classification 'T' (Toxic) — chronic heavy use (>5 drinks/day for >5 yr)
  • Smoking — independent and synergistic risk; accelerates progression
  • Genetic — PRSS1 (hereditary pancreatitis, autosomal dominant), SPINK1, CFTR, CTRC mutations
  • Autoimmune pancreatitis — IgG4-related (type 1) or duct-centric (type 2, IBD-associated)
  • Obstructive — pancreas divisum, sphincter of Oddi dysfunction, post-traumatic stricture, neoplasm
  • Recurrent acute pancreatitis (any cause)
  • Idiopathic (~20%)
  • Tropical (calcific) pancreatitis (developing countries)

Pathophysiology

TIGAR-O etiologic classification (Toxic-metabolic, Idiopathic, Genetic, Autoimmune, Recurrent acute, Obstructive). Repeated acinar injury triggers stellate cell activation, collagen deposition, ductal stricture, calcification, and progressive parenchymal loss. Exocrine insufficiency develops when >90% of acinar function is lost.

Clinical presentation

Symptoms

  • Chronic, intermittent or constant epigastric pain — postprandial, radiates to back, may be relieved by leaning forward
  • Steatorrhea — pale, bulky, foul-smelling stools that float
  • Weight loss and malnutrition
  • Symptoms of diabetes (polyuria, polydipsia, fatigue)
  • Fat-soluble vitamin deficiency (ADEK) symptoms — bleeding (K), bone disease (D), neuropathy (E), night blindness (A)
  • Some patients have minimal pain (especially late-stage 'burned-out' CP)

Signs / physical exam

  • Cachexia, temporal wasting
  • Epigastric tenderness (less prominent than in acute pancreatitis)
  • Bronze skin (hemochromatosis with pancreatic involvement — rare)
  • Signs of fat-soluble vitamin deficiency
  • Diabetic complications

Classic findings

Triad of pancreatic calcifications + steatorrhea + diabetes mellitus is pathognomonic but late.

Differential diagnosis

  • Recurrent acute pancreatitis — Distinct episodes with normalization between; lipase rises and falls; may evolve to CP
  • Pancreatic adenocarcinoma — Painless jaundice in head tumors; mass and ductal dilation on imaging; weight loss; CA 19-9 elevated
  • Functional dyspepsia / IBS — Normal imaging, normal pancreatic function tests
  • Mesenteric ischemia — Postprandial pain, weight loss, atherosclerotic risk factors; CT angiography
  • Peptic ulcer / gastritis — Burning epigastric pain; EGD
  • Biliary disease (chronic cholestasis, PSC) — Imaging and LFTs
  • Pancreatic pseudocyst — Complication of CP; mass effect, pain
  • Cystic neoplasm (IPMN, MCN, SCA) — Cystic lesions; MRCP, EUS-FNA

Diagnostic workup

Diagnostic criteria

Established CP: characteristic imaging findings (calcifications, ductal dilation, pseudocysts) + symptoms ± exocrine/endocrine insufficiency. Early CP: more challenging; EUS Rosemont criteria, pancreatic function testing, and longitudinal observation.

Labs

  • Lipase/amylase — often NORMAL in established CP (atrophic gland); elevated only during flares
  • BMP, calcium, magnesium
  • Fecal elastase-1 — <200 mcg/g suggests exocrine insufficiency (<100 = severe)
  • 72-h fecal fat collection — >7 g fat/day on 100 g fat diet confirms steatorrhea (gold standard, rarely performed)
  • Fasting glucose, HbA1c — screen for diabetes
  • Fat-soluble vitamin levels (A, D, E, K — INR as surrogate for K)
  • B12 (intrinsic factor and acid-dependent absorption may be affected indirectly)
  • Lipid panel, triglycerides
  • Autoimmune workup if suspected: IgG4, ANA
  • Genetic testing in young patients or family history (PRSS1, SPINK1, CFTR, CTRC)

Imaging

  • CT abdomen — pancreatic calcifications (pathognomonic), ductal dilation, parenchymal atrophy, pseudocysts
  • MRCP — main pancreatic duct dilation and side-branch ectasia (chain of lakes appearance); without and with secretin enhancement
  • EUS — most sensitive for early CP; Rosemont criteria (hyperechoic foci, hyperechoic strands, lobularity, cysts, calcifications, duct dilation, hyperechoic duct margins, side branch dilation, irregular duct contour)
  • ERCP — historically used for diagnosis; now mainly therapeutic (stenting, stone extraction) due to pancreatitis risk
  • Secretin-enhanced MRCP — assess ductal compliance and bicarbonate output

Diagnostic algorithm

TIGAR-O CategoryExamples
T — Toxic-metabolicAlcohol, smoking, hypercalcemia, hypertriglyceridemia, chronic renal failure, medications
I — IdiopathicEarly-onset, late-onset, tropical
G — GeneticPRSS1 (hereditary), SPINK1, CFTR, CTRC
A — AutoimmuneType 1 (IgG4-related), Type 2 (duct-centric, IBD-associated)
R — Recurrent acuteRecurrent severe AP, post-necrotic, vascular/ischemic, post-irradiation
O — ObstructivePancreas divisum, sphincter of Oddi dysfunction, neoplasm, post-traumatic stricture
TIGAR-O etiologic classification of chronic pancreatitis.

Treatment

First-line

  • Alcohol cessation (single most important intervention)
  • Smoking cessation (independent and synergistic risk)
  • Pain management: acetaminophen, NSAIDs, gabapentinoids; opioids judiciously (high addiction risk); tricyclic antidepressants for neuropathic component
  • Pancreatic enzyme replacement therapy (PERT) — pancrelipase 25,000-75,000 lipase units with meals and 10,000-25,000 with snacks; uncoated formulation with concurrent PPI for some patients
  • Treat diabetes — insulin often required (type 3c diabetes — brittle, prone to hypoglycemia due to glucagon deficiency)
  • Nutritional support: low-fat diet only if severe steatorrhea; supplement fat-soluble vitamins (ADEK), calcium, B12
  • Manage osteopenia/osteoporosis (DEXA, vitamin D, bisphosphonates)

Second-line / adjunct

  • Endoscopic therapy: ERCP with pancreatic duct stenting, stone extraction, ESWL for large stones — selected patients with ductal disease
  • Surgical decompression — lateral pancreaticojejunostomy (Puestow) for dilated main duct (>7 mm) and refractory pain; Frey, Beger, or Whipple procedures for head-predominant disease
  • Celiac plexus block (limited durability)
  • Total pancreatectomy with islet auto-transplantation — refractory pain with debilitating disease (specialized centers)
  • Treat IgG4-related autoimmune pancreatitis with corticosteroids — DRAMATIC response (often confused with cancer); maintain with low-dose steroid or rituximab

Complications

  • Chronic pain and opioid dependence
  • Exocrine insufficiency — steatorrhea, malnutrition, fat-soluble vitamin deficiency, B12 deficiency
  • Endocrine insufficiency — diabetes mellitus (type 3c — brittle, hypoglycemia-prone)
  • Pancreatic pseudocyst (drainage if symptomatic, infected, or persistent)
  • Pseudoaneurysm (splenic artery) → hemorrhage
  • Splenic vein thrombosis → isolated gastric varices (sinistral hypertension)
  • Biliary stricture from pancreatic head fibrosis → obstructive jaundice
  • Duodenal stricture / gastric outlet obstruction
  • Pancreatic adenocarcinoma (4× baseline risk; higher in hereditary pancreatitis)
  • Osteoporosis

PANCE pearls

  • Lipase is often NORMAL in established CP — atrophic gland produces less enzyme. Do not exclude CP based on normal lipase.
  • Pancreatic calcifications + steatorrhea + diabetes = late-stage CP (textbook triad).
  • Type 3c diabetes (pancreatogenic) is brittle and prone to severe hypoglycemia from glucagon deficiency — counsel patients and consider continuous glucose monitoring.
  • Pancreatic enzyme replacement (PERT) — dose 25,000-50,000 lipase units per meal; concurrent PPI for non-enteric-coated formulations; titrate to symptom control.
  • Always exclude pancreatic cancer in patients with new or worsening pain — CT, MRI, EUS-FNA as indicated.
  • IgG4-related autoimmune pancreatitis (type 1) responds dramatically to corticosteroids — sausage-shaped pancreas, elevated IgG4, other organ involvement (sclerosing cholangitis, retroperitoneal fibrosis, sialadenitis).
  • PRSS1 mutation (hereditary pancreatitis) — 80% lifetime risk of CP; consider screening for pancreatic cancer.
  • Smoking accelerates CP progression independently — counseling cessation is critical.
  • Total pancreatectomy with islet auto-transplantation can be considered in highly selected refractory patients at experienced centers.
  • Tropical (juvenile) calcific pancreatitis: developing countries; SPINK1 mutations; large ductal stones; presents in adolescence with severe pain and diabetes.

References

  • ACG 2020 — Gardner TB et al. ACG Clinical Guideline: Chronic Pancreatitis. Am J Gastroenterol 2020;115:322-339
  • AGA 2020 — Singh VK et al. AGA Clinical Practice Update on Evaluation and Management of Exocrine Pancreatic Insufficiency: Expert Review. Gastroenterology 2020;159:1972-1987
  • International Consensus — Whitcomb DC et al. International consensus guidelines for nutrition therapy in pancreatitis. Pancreatology 2018;18:847-854

Practice Gastrointestinal questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Related Gastrointestinal diagnoses

Gastroesophageal Reflux Disease (GERD)Peptic Ulcer Disease (PUD)Helicobacter pylori InfectionEosinophilic Esophagitis (EoE)Esophageal VaricesAchalasiaEsophageal CancerGastric CancerIrritable Bowel Syndrome (IBS)Crohn DiseaseUlcerative Colitis (UC)Diverticulitis and DiverticulosisColorectal Cancer (CRC)Hemorrhoids

Differentials & related conditions

Pancreatic AdenocarcinomaMesenteric Ischemia (Acute and Chronic)

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.